Market icon

Will RFK end any vaccine approvals by December 31?

<1% chance
Polymarket

$7,093 Vol.

This market will resolve to "Yes" if any vaccine has its Biologics License Application (BLA) approval or Emergency Use Authorization (EUA) revoked by the FDA or is voluntarily withdrawn for reasons related to health, safety, or efficacy by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”.

Withdrawing approval solely due to seasonality, low demand, or an emergency ending will not be sufficient for a "Yes" resolution. Similarly, a reduction in the scope of approved recipients, without fully eliminating the approval will not be sufficient for a "Yes" resolution."

The resolution source will be official FDA announcements and guidance published on the FDA website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
볼륨
$7,093
종료일
Dec 31, 2025
생성일
Sep 3, 2025, 11:16 PM ET
This market will resolve to "Yes" if any vaccine has its Biologics License Application (BLA) approval or Emergency Use Authorization (EUA) revoked by the FDA or is voluntarily withdrawn for reasons related to health, safety, or efficacy by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”. Withdrawing approval solely due to seasonality, low demand, or an emergency ending will not be sufficient for a "Yes" resolution. Similarly, a reduction in the scope of approved recipients, without fully eliminating the approval will not be sufficient for a "Yes" resolution." The resolution source will be official FDA announcements and guidance published on the FDA website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).

제안된 결과: No

이의 없음

최종 결과: No

외부 링크를 조심하십시오.

Market icon

Will RFK end any vaccine approvals by December 31?

<1% chance
Polymarket

$7,093 Vol.

This market will resolve to "Yes" if any vaccine has its Biologics License Application (BLA) approval or Emergency Use Authorization (EUA) revoked by the FDA or is voluntarily withdrawn for reasons related to health, safety, or efficacy by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”.

Withdrawing approval solely due to seasonality, low demand, or an emergency ending will not be sufficient for a "Yes" resolution. Similarly, a reduction in the scope of approved recipients, without fully eliminating the approval will not be sufficient for a "Yes" resolution."

The resolution source will be official FDA announcements and guidance published on the FDA website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
볼륨
$7,093
종료일
Dec 31, 2025
생성일
Sep 3, 2025, 11:16 PM ET
This market will resolve to "Yes" if any vaccine has its Biologics License Application (BLA) approval or Emergency Use Authorization (EUA) revoked by the FDA or is voluntarily withdrawn for reasons related to health, safety, or efficacy by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”. Withdrawing approval solely due to seasonality, low demand, or an emergency ending will not be sufficient for a "Yes" resolution. Similarly, a reduction in the scope of approved recipients, without fully eliminating the approval will not be sufficient for a "Yes" resolution." The resolution source will be official FDA announcements and guidance published on the FDA website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).

제안된 결과: No

이의 없음

최종 결과: No

외부 링크를 조심하십시오.